Prudens Dermaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 23-10-2024
- Paid Up Capital ₹ 0.10 M
as on 23-10-2024
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.05 Cr
as on 23-10-2024
- Revenue 105.36%
(FY 2023)
- Profit -5.93%
(FY 2023)
- Ebitda 42.07%
(FY 2023)
- Net Worth 73.07%
(FY 2023)
- Total Assets 57.65%
(FY 2023)
About Prudens Dermaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.05 Cr.
Rahul Karwande, Rahul Ghule, Ameya Mukund, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999PN2017PTC172425
- Company No.
172425
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Sep 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- LocationPune, Maharashtra
- Telephone
- Email Address
- Website
- Social Media
What products or services does Prudens Dermaceuticals Private Limited offer?
Prudens Dermaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Skin Lightening Drugs, Infusion Syringes & Supplies, Blood Collection Tubes, UV Sterilizer and Lamps, Salon, Spa Kits & Equipments, Steamer & Massager Equipment, Hair Growth Medicine.
Who are the key members and board of directors at Prudens Dermaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Ghule  | Director | 08-Sep-2017 | Current |
| Ameya Mukund | Director | 08-Sep-2017 | Current |
| Rahul Karwande | Director | 08-Sep-2017 | Current |
| Pavan Waghrulkar | Director | 08-Sep-2017 | Current |
Financial Performance of Prudens Dermaceuticals.
Prudens Dermaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 105.36% increase. The company also saw a slight decrease in profitability, with a 5.93% decrease in profit. The company's net worth Soared by an impressive increase of 73.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prudens Dermaceuticals?
In 2023, Prudens Dermaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jp Esthetics Private LimitedActive 4 years 10 monthsRahul Karwande, Rahul Ghule and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 12 Jun 2024 | ₹1.05 Cr | Open |
How Many Employees Work at Prudens Dermaceuticals?
Unlock and access historical data on people associated with Prudens Dermaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prudens Dermaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prudens Dermaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
